Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership
Abstract Background Accurate capture and reporting of adverse events (AEs) in clinical trials is critical to understanding the potential harms of prospective interventions. Current AE-reporting frameworks are specifically constructed for pharmacological interventions and adaptation of these framewor...
Saved in:
| Main Authors: | Rayan Saleh Moussa, Jack Power, Vanessa Yenson, Belinda Fazekas, Celia Marston, Annmarie Hosie, Layla Edwards, Domenica Disalvo, Linda Brown, Imelda Gilmore, John Stubbs, Andrea Cross, Sally Fielding, Meera R. Agar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Trials |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13063-025-08801-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delirium researchers' perspectives of the challenges in delirium biomarker research: A qualitative study.
by: Ingrid Amgarth-Duff, et al.
Published: (2021-01-01) -
The functional role of CST1 and CCL26 in asthma development
by: Angela Hoyer, et al.
Published: (2024-01-01) -
Simulation study of proton beam extraction process based on CST software
by: Renli Zhu, et al.
Published: (2025-03-01) -
CSTAN: A Deepfake Detection Network with CST Attention for Superior Generalization
by: Rui Yang, et al.
Published: (2024-11-01) -
Serum Cystatin S (CST4): A Novel Prognostic Marker for Gastric Cancer
by: Chao Gu, et al.
Published: (2025-01-01)